SUN-643 - Beyond Hyperglycemia: GLP-1 Receptor Agonists Are Associated With Improved Systemic Inflammatory Outcomes in IBD With Type 2 Diabetes and Obesity.

Late-Breaking Poster Presenter(s)

• BS

  Brandy H. Sullivan, MD, MPH

  Tulane University School of Medicine
  KENNER, United States

Senior Author/Primary Investigator(s)

• BS

  Brandy H. Sullivan, MD, MPH

  Tulane University School of Medicine
  KENNER, United States

Co-Author(s)

• BS

  Brandy H. Sullivan, MD, MPH

  Tulane University School of Medicine
  KENNER, United States
• BG

  Benjamin M. Glickman, MD

  Tulane University School of Medicine
  New Orleans, Louisiana, United States
• MV

  Meghana Vankina, MD

  Tulane University School of Medicine
  New Orleans, Louisiana, United States

Senior Author/Primary Investigator(s)

• 

  Dragana Lovre, MD

  Associate Professor
  Tulane University School of Medicine
  New Orleans, LA, United States

Co-Author(s)

• 

  Dragana Lovre, MD

  Associate Professor
  Tulane University School of Medicine
  New Orleans, LA, United States